Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting

American Journal of Cardiology

Volumn 84, Issue 6, 1999, Pages 726-728

  Jauhar, Rajiv ^a   Bergman, Geoffrey ^a   Savino, Sara ^a   Deutsch, Ezra ^a   Shaknovich, Alexander ^a   Parikh, Manish ^a   Sanborn, Timothy A ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; CLOPIDOGREL; HEPARIN; TICLOPIDINE;

ADULT; AGED; ATHERECTOMY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; RISK FACTOR; SHORT SURVEY; SMOKING; THROMBOSIS; ULTRASOUND;

EID: 0033568144     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00420-8     Document Type: Article

References (18)

1. Hermann H.C., Buchbinder M., Clemen M.W., Fischman P., Goldberg S., Leon M., Schatz R.A., Tierstein P., Walker C.M., Hirshfield J.W. Emergent use of balloon-expandable coronary stenting for failed percutaneous transluminal coronary angioplasty. Circulation. 86:1992;812-819.
2. Serruys P.W., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., Emanuelsson H., Marco J., Legrand V., Materne P., Belardi J., Sigwart U., Colombo A., Goy J.-J., van den Huevel P., Delcan J., Morel M.A. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 331:1994;496-501.
3. Fischman D.L., Leon M.B., Baim D.S., Schatz R.A., Penn I., Detre K., Savage M.P., Veltri L., Ricci D., Nobuyoshi M., Cleman M., Heuser R., Almond D., Teirstein P., Fish D., Colombo A., Brinker J., Moses J., Hirshfeld J., Bailey S., Ellis S., Rake R., Goldberg S. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 331:1994;496-501.
4. Serruys P.W., Strauss B.H., Beatt K.J. Angiographic followup after placement of a self expanding coronary artery stent. N Engl J Med. 321:1991;13-17.
5. Morice M.C., Zemour G., Benveniste E., Biron Y., Bourdonnec C., Faivre R., Fajadet J., Gaspard P., Glatt B., Joly P., Labrunie P., Lienhart Y., Marco J., Petiteau P.Y., Royer T., Valeix B. Intracoronary stenting without coumadin one month results of a French multicenter study . Cathet Cardiovasc Diagn. 35:1995;1-7.
6. Goods C.M., Al-Shaibi K.F., Liu M.W., Yadav J.S., Mathur A., Jain S.P., Dean L.S., Iyer S.S., Parks J.M., Roubin G.S. Comparison of Aspirin alone versus Aspirin plus Ticlopidine after Coronary Artery Stenting. Am J Cardiol. 78:1996;1042-1044.
7. Albiero R., Hall P., Itoh A., Blengino S., Nakamura S., Martini G., Ferraro M., Colombo A. Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Circulation. 95:1997;1145-1156.
8. Leon M.B., Baim D.S., Popma J.J., Gordon P.C., Cutlip D.E., Ho K.K.L., Giambartolomei A., Diver D.J., Lasorda D.M., Williams D.O., Pocock S.J., Kuntz R.E. A clinical trial comparing three antithrombotic-drug regimens after coronary artery stenting. N Engl J Med. 339:1998;1665-1671.
9. Urban P., Macaya C., Rupprecht H.-J., Kiemeneij F., Emanuelsson H., Fontanelli A., Pieper M., Wesseling T., Sagnard L. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients. Circulation. 98:1998;2126-2132.
10. Bertrand M., Legrand V., Boland J., Fleck E., Bonnier J., Emmanuelson H., Vrolix M., Missault L., Chierchia S., Casaccia M., Niccoli L., Oto A., White C., Webb-Peploe M., Van Belle E., McFadden E.P. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. Circulation. 98:1998;1597-1603.
11. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet. 348:1996;1329-1339.
12. Neumann F.J., Gawaz M., Dickfeld T., Wehinger A., Walter H., Blasini R., Schomig A. Antiplatelet effect of ticlopidine after coronary stenting. J Am Coll Cardiol. 29:1997;1515-1519.
13. Schomig A., Neumann F.J., Kastrati A., Schulen H., Blasini R., Hadamitzky M., Walter H., Zitzmann-Roth E.-M., Richardt G., Alt E., Schmitt C., Ulm K. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med. 335:1996;1084-1089.
14. Hall P., Nakamura S., Maiello L., Itoh A., Blengino S., Martini G., Ferraro M., Colombo A. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation. 93:1996;215-222.
15. Schuhlen H., Kastrati A., Dirschinger J., Hausleiter J., Elezi S., Wehinger A., Pache J., Hadamitzky M., Schomig A. Intracoronary stenting and risk for major adverse cardiac events during the first month. Circulation. 98:1998;104-111.
16. Schomig A., Kastrati A., Schuhlen H., Elezi S., Hausleiter J., Dirschinger J. Risk factor analysis for stent occlusion within the first month after successful coronary stent placement. J Am Coll Cardiol. 31:(suppl A):1998;99A.
17. Bennett C.L., Kiss J.E., Weinberg P.D., Pinevich A.J., Green D., Kwaan H.C., Feldman M.D. Thrombotic thrombocytopenic purpura after stent, and ticlopidine. Lancet. 352:1998;1036-1037.
18. Bachman F., Savolo M., Hauert J., Geudelin B., Kleffer G., Carlou R. Rapid onset of inhibition of ADP-induced platelet aggregation by a loading dose of clopidogrel. (abstr) Eur Heart J. 17:(suppl):1996;263.